MEANS TO OPTIMIZE THE TREATMENT OF DYSLIPIDEMIA IN PATIENTS WITH HYPOTHYROIDISM | Zendy

О.М. Didushko | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

MEANS TO OPTIMIZE THE TREATMENT OF DYSLIPIDEMIA IN PATIENTS WITH HYPOTHYROIDISM

Author(s) -

О.М. Didushko

Publication year - 2021

Publication title -

problems of endocrine pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.141

H-Index - 2

eISSN - 2518-1432

pISSN - 2227-4782

DOI - 10.21856/j-pep.2015.4.02

Subject(s) - dyslipidemia , atorvastatin , medicine , endocrinology , hormone , lipid metabolism , lipid profile , abdominal obesity , body mass index , thyroid , thyroid stimulating hormone , obesity , cholesterol , metabolic syndrome

In order to study the peculiarities of lipid metabolism and atorvastatin efficacy for patients with hypothyroidism, it was examined 133 patients with manifested hypothyroidism. It was revealed malfunction lipid metabolism, i. e. a direct correlation between total cholesterol levels and thyroidstimulating hormone (TSH). It was confirmed, that higher indices of dyslipidemia are associated with the most manifested abdominal obesity and with higher body mass index. Reaching of normal levels of thyroid-stimulating hormone during hormone-replacing therapy is not sufficient to gain the required levels of major indices in lipid profile. It was proved efficacy of atorvastatin in complex treatment of hypothyroidism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research